ORAMED PHARMACEUTICALS INC.

For the period ended Jun 30, 2025. Filed Aug 14, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Aug 14, 2025

ORMP$3.97-0.7%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Comprehensive Income

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

Six months ended · Three months ended
June 30, · June 30, · June 30, · June 30,
2025 · 2024 · 2025 · 2024
REVENUES	$2,000	-	$	-	-
COST OF REVENUE	(1,987)	-		-	-
GROSS PROFIT	13	-		-	-
RESEARCH AND DEVELOPMENT EXPENSES	(3,240)	(2,621)		(1,034)	(1,442)
GENERAL AND ADMINISTRATIVE EXPENSES	(3,762)	(3,476)		(1,455)	(1,693)
OPERATING LOSS	(6,989)	(6,097)		(2,489)	(3,135)
OTHER INCOME, NET	257	-		257	-
FINANCIAL INCOME, NET	12,808	19,322		15,366	14,234
INTEREST EXPENSES	-	(853)		-	(261)
INCOME BEFORE TAX EXPENSES	$6,076	12,372		$13,134	10,838
TAX BENEFIT (EXPENSES)	(458)	(1,634)		126	(1,634)
NET INCOME	$5,618	10,738		$13,260	9,204
NET INCOME (LOSS) ATTRIBUTABLE TO:
NON-CONTROLLING INTERESTS	(28)	(10)		(28)	(8)
COMPANY’S STOCKHOLDERS	5,646	10,748		13,288	9,212
BASIC INCOME PER SHARE OF COMMON STOCK	$0.14	$0.26		$0.32	$0.22
DILUTED INCOME PER SHARE OF COMMON STOCK	$0.13	$0.26		$0.31	$0.22
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING BASIC INCOME PER SHARE OF COMMON STOCK	41,488,994	40,899,275		41,743,486	40,959,759
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING DILUTED INCOME PER SHARE OF COMMON STOCK	42,884,004	41,427,849		42,609,425	41,591,007

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.